MX2011005370A - Formas de dosis orales de sufentanilo que comprenden agentes barredores de oxígeno y métodos de uso de los mismos. - Google Patents

Formas de dosis orales de sufentanilo que comprenden agentes barredores de oxígeno y métodos de uso de los mismos.

Info

Publication number
MX2011005370A
MX2011005370A MX2011005370A MX2011005370A MX2011005370A MX 2011005370 A MX2011005370 A MX 2011005370A MX 2011005370 A MX2011005370 A MX 2011005370A MX 2011005370 A MX2011005370 A MX 2011005370A MX 2011005370 A MX2011005370 A MX 2011005370A
Authority
MX
Mexico
Prior art keywords
sufentanil
dosage forms
solid dosage
methods
same
Prior art date
Application number
MX2011005370A
Other languages
English (en)
Inventor
Shamim Pushpala
Larry Hamel
Stelios Tzannis
Evangeline Cruz
Original Assignee
Acelrx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acelrx Pharmaceuticals Inc filed Critical Acelrx Pharmaceuticals Inc
Publication of MX2011005370A publication Critical patent/MX2011005370A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Se proveen composiciones y métodos efectivos para minimizar o eliminar la presencia de productos de degradación oxidativa en formas de dosis orales que comprenden sufentanilo.
MX2011005370A 2008-11-21 2009-11-12 Formas de dosis orales de sufentanilo que comprenden agentes barredores de oxígeno y métodos de uso de los mismos. MX2011005370A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/275,485 US8945592B2 (en) 2008-11-21 2008-11-21 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
PCT/US2009/064232 WO2010059504A1 (en) 2008-11-21 2009-11-12 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same

Publications (1)

Publication Number Publication Date
MX2011005370A true MX2011005370A (es) 2011-09-15

Family

ID=41720575

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011005370A MX2011005370A (es) 2008-11-21 2009-11-12 Formas de dosis orales de sufentanilo que comprenden agentes barredores de oxígeno y métodos de uso de los mismos.

Country Status (17)

Country Link
US (1) US8945592B2 (es)
EP (1) EP2367537B1 (es)
JP (1) JP2012509325A (es)
KR (1) KR20110099017A (es)
CN (1) CN102231980B (es)
AU (1) AU2009316874B2 (es)
BR (1) BRPI0921519B1 (es)
CA (1) CA2743261C (es)
DK (1) DK2367537T3 (es)
ES (1) ES2396150T3 (es)
IL (1) IL212880A (es)
MX (1) MX2011005370A (es)
NZ (1) NZ593512A (es)
PT (1) PT2367537E (es)
RU (1) RU2530579C2 (es)
SG (1) SG171786A1 (es)
WO (1) WO2010059504A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357114B2 (en) * 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8865743B2 (en) * 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9289583B2 (en) * 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
AU2008216867B2 (en) 2007-02-09 2014-01-30 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
ES2635137T3 (es) * 2007-08-07 2017-10-02 Acelrx Pharmaceuticals, Inc. Formas de dosificación oral transmucosal que comprenden sufentanilo y triazolam
US8548623B2 (en) * 2009-03-18 2013-10-01 Acelrx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
RS55489B1 (sr) 2012-05-02 2017-04-28 Orexo Ab Novi preparati alfentanila za tretman akutnog bola
BR112017013311B1 (pt) 2014-12-23 2022-05-31 Acelrx Pharmaceuticals, Inc Aparelho para a dispensação de formas de dosagem via oral e transmucosal
EP4223330A1 (en) 2015-10-30 2023-08-09 AcelRx Pharmaceuticals, Inc. Apparatus and methods for dispensing oral transmucosal dosage forms

Family Cites Families (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2621655A (en) 1951-10-11 1952-12-16 Kenneth L Gothard Tablet dispensing gun
GB1142325A (en) * 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
FR2278317A1 (fr) * 1974-07-19 1976-02-13 Commissariat Energie Atomique Implant buccal pour administrer des produits solubilisables
US4237884A (en) * 1978-03-17 1980-12-09 Victor Erickson Medication dispenser
DE2844110A1 (de) * 1978-10-10 1980-04-24 Bosch Gmbh Robert Handwerkzeugmaschine, insbesondere meisselhammer
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4229447A (en) 1979-06-04 1980-10-21 American Home Products Corporation Intraoral methods of using benzodiazepines
US4474308A (en) * 1982-09-30 1984-10-02 Michel Bergeron Tablet ejector
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US5855908A (en) * 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
US5288498A (en) 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
DE3421468A1 (de) 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5132114A (en) 1985-05-01 1992-07-21 University Of Utah Research Foundation Compositions and methods of manufacture of compressed powder medicaments
US5785989A (en) 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
US5122127A (en) 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US5288497A (en) 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4671953A (en) 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4785969A (en) * 1986-11-10 1988-11-22 Pyxis Corporation Medication dispensing system
DE3855054T2 (de) * 1987-05-26 1996-07-18 Sumitomo Pharma Vorrichtung zur Verabreichung von festen Präparaten
FR2619718B1 (fr) * 1987-09-02 1991-07-12 Medibrevex Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
US4873076A (en) * 1988-04-29 1989-10-10 Baker Cummins Pharmaceuticals, Inc. Method of safely providing anesthesia or conscious sedation
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5112616A (en) * 1988-11-30 1992-05-12 Schering Corporation Fast dissolving buccal tablet
US5223264A (en) 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
WO1992016236A1 (en) 1991-03-19 1992-10-01 Rajadhyaksha Vithal J Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5296234A (en) * 1991-10-11 1994-03-22 Abbott Laboratories Holder and packaging for a hardened medicated matrix
US5348158A (en) * 1991-12-19 1994-09-20 G. D. Searle & Co. Dispenser pack for the successive dispensing of a drug
US5352680A (en) * 1992-07-15 1994-10-04 Regents Of The University Of Minnesota Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
US5724957A (en) 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US5694919A (en) 1993-01-29 1997-12-09 Aradigm Corporation Lockout device for controlled release of drug from patient-activated dispenser
US5507277A (en) 1993-01-29 1996-04-16 Aradigm Corporation Lockout device for controlled release of drug from patient-activateddispenser
US5489689A (en) * 1993-09-30 1996-02-06 Mallinckrodt Chemical, Inc. Preparation of piperidine derivatives
US5489025A (en) * 1994-03-01 1996-02-06 Romick; Jerome M. Unit-dose medication dispenser and multiple-dispenser frame therefor
US5507807A (en) * 1994-03-01 1996-04-16 Shippert; Ronald D. Apparatus for the release of a substance within a patient
US6328159B1 (en) * 1994-07-13 2001-12-11 Centrix, Inc Single patient dose medicament dispenser with applicator
US5660273A (en) * 1994-07-13 1997-08-26 Centrix, Inc. Single patient dose medicament dispenser with applicator
US6685013B2 (en) * 1994-07-13 2004-02-03 Centrix, Inc. Single patient dose medicament dispenser with applicator
WO1996008284A2 (en) 1994-09-16 1996-03-21 Laboratoire Glaxo Wellcome Inhalation device
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
CA2218369C (en) 1995-06-05 2010-02-09 Alza Corporation Transdermal electrotransport delivery of fentanyl and sufentanil
WO1996040332A1 (en) 1995-06-07 1996-12-19 O'neil, Christine Patient controlled drug delivery device
US5710551A (en) 1995-07-26 1998-01-20 Ridgeway; Donald G. Self-medication monitoring system
CA2184316A1 (en) * 1995-09-12 1997-03-13 Wei-Chi Liao Buccal delivery system for therapeutic agents
AUPN603895A0 (en) 1995-10-19 1995-11-09 University Of Queensland, The Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
GB2309966A (en) 1996-02-07 1997-08-13 Harwill Ind Pty Ltd Teat device for administering medicaments
US5995938A (en) 1996-02-27 1999-11-30 Whaley; Susan S. Medication compliance system
NL1003596C2 (nl) 1996-07-15 1997-05-27 Cons Health Entrepreneurs Bv Geneesmiddelafgifte-automaat.
US6248789B1 (en) 1996-08-29 2001-06-19 Stuart L. Weg Administration of ketamine to manage pain and to reduce drug dependency
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5954641A (en) * 1997-09-08 1999-09-21 Informedix, Inc. Method, apparatus and operating system for managing the administration of medication and medical treatment regimens
US5752620A (en) * 1996-11-13 1998-05-19 Pearson Ventures, L.L.C. Medication dispenser
US6529446B1 (en) * 1996-12-20 2003-03-04 Telaric L.L.C. Interactive medication container
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5950632A (en) 1997-03-03 1999-09-14 Motorola, Inc. Medical communication apparatus, system, and method
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US5945651A (en) * 1997-07-17 1999-08-31 Chorosinski; Leonard Remotely programmable medication dispensing system
JPH1147233A (ja) * 1997-07-30 1999-02-23 Teikoku Seiyaku Co Ltd 貼付剤および貼付剤の保存方法
US5850937A (en) 1997-08-14 1998-12-22 Rauche; Stephen J. Dispenser with means for alerting a user
AU9062998A (en) * 1997-09-11 1999-03-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
IL135258A0 (en) * 1997-09-26 2001-05-20 Noven Pharma Bioadhesive compositions and methods for topical administration of active agents
US6660295B2 (en) * 1997-09-30 2003-12-09 Alza Corporation Transdermal drug delivery device package with improved drug stability
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
AU759018B2 (en) * 1997-10-03 2003-04-03 Warner-Lambert Company Compressed nitroglycerin tablet and its method of manufacture
US5997518A (en) 1998-01-14 1999-12-07 Laibovitz; Robert A. Apparatus and method for delivery of small volumes of liquid
KR20010040398A (ko) 1998-01-23 2001-05-15 마가렛 에이.혼 화학적으로 개질된 돌연변이 효소 및 이를 제조하는 방법및 스크리닝하는 방법
US5981552A (en) * 1998-10-23 1999-11-09 Taylor Pharmaceuticals Sublingual and buccal compositions of droperidol and method for treating migraine
US6576250B1 (en) 1998-03-27 2003-06-10 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6039251A (en) * 1998-04-16 2000-03-21 Holowko; Paul L. Method and system for secure control of a medical device
ATE309021T1 (de) * 1998-08-28 2005-11-15 Glaxo Group Ltd Spender
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
GB9826192D0 (en) * 1998-12-01 1999-01-20 Controlled Theraputics Scotlan Oral transmucosal delivery
AU2879100A (en) * 1999-02-12 2000-08-29 Miles A. Libbey Iii Formulation and system for intra-oral delivery of pharmaceutical agents
US6680071B1 (en) 1999-03-03 2004-01-20 R. P. Scherer Technologies, Inc. Opioid agonist in a fast dispersing dosage form
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6601729B1 (en) 1999-03-26 2003-08-05 Papp Enterprises, Llc Automated portable medication radial dispensing apparatus and method using a carrier tape
US6234343B1 (en) 1999-03-26 2001-05-22 Papp Enterprises, Llc Automated portable medication radial dispensing apparatus and method
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
US6762684B1 (en) * 1999-04-19 2004-07-13 Accutrak Systems, Inc. Monitoring system
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
US6190326B1 (en) * 1999-04-23 2001-02-20 Medtrac Technologies, Inc. Method and apparatus for obtaining patient respiratory data
GB9911388D0 (en) * 1999-05-18 1999-07-14 Glaxo Group Ltd Dispenser
US7919119B2 (en) 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6395300B1 (en) 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
AU6634000A (en) * 1999-08-13 2001-03-13 Vela Pharmaceuticals Inc. Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof
US6264983B1 (en) * 1999-09-16 2001-07-24 Rhodia, Inc. Directly compressible, ultra fine acetaminophen compositions and process for producing same
FR2799124B1 (fr) * 1999-10-01 2004-08-13 Sanofi Synthelabo Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
US6382204B1 (en) 1999-10-14 2002-05-07 Becton Dickinson And Company Drug delivery system including holder and drug container
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
AU2427201A (en) 1999-12-06 2001-06-12 Mallinckrodt, Inc. New methods for the syntheses of alfentanil, sufentanil and remifentanil
PE20010720A1 (es) * 1999-12-11 2001-07-26 Glaxo Group Ltd Distribuidor de medicamento
AT408488B (de) 1999-12-22 2001-12-27 Scan Messtechnik Gmbh Miniaturisiertes spektrometer
US6294999B1 (en) 1999-12-29 2001-09-25 Becton, Dickinson And Company Systems and methods for monitoring patient compliance with medication regimens
US6471645B1 (en) * 1999-12-30 2002-10-29 Medtronic, Inc. Communications system for an implantable device and a drug dispenser
PL204106B1 (pl) 2000-02-28 2009-12-31 Pharmakodex Ltd Zestaw do dostarczania środka terapeutycznego
WO2002011778A1 (en) 2000-05-10 2002-02-14 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
DE10025946A1 (de) 2000-05-26 2001-11-29 Gruenenthal Gmbh Wirkstoffkombination
AT409366B (de) 2000-06-20 2002-07-25 Haas Beteiligungsgesellschaft Magazin zur aufnahme und vereinzelten abgabe von tabletten
US20030190290A1 (en) 2000-06-22 2003-10-09 Calvin Ross Pharmaceutical compositions
ES2302742T5 (es) 2000-07-31 2011-10-10 Nycomed Danmark Aps Pulverizador nasal para suministrar una composición farmacéutica.
ES2265439T3 (es) 2000-08-18 2007-02-16 Pharmacia Corporation Formulacion oral de valdecoxib que se desintegra rapidamente.
US20020026330A1 (en) 2000-08-23 2002-02-28 Klein Edward E. System and method for patient medication management and compliance using a portable computing device
US6417184B1 (en) 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
GB2368061B (en) 2000-10-20 2005-05-11 Gw Pharmaceuticals Ltd Dose dispensing apparatus
US20050054942A1 (en) 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
US20020160043A1 (en) 2001-02-27 2002-10-31 Dennis Coleman Compositions and method of manufacture for oral dissolvable dosage forms
DE10109763A1 (de) 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
US20050176790A1 (en) * 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
JP4850346B2 (ja) 2001-03-15 2012-01-11 救急薬品工業株式会社 粘膜貼付剤
EP1243524A3 (en) * 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
GB0108228D0 (en) * 2001-04-02 2001-05-23 Glaxo Group Ltd Medicament dispenser
GB0108215D0 (en) 2001-04-02 2001-05-23 Glaxo Group Ltd Medicament dispenser
US7125561B2 (en) 2001-05-22 2006-10-24 Euro-Celtique S.A. Compartmentalized dosage form
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
AU2002310085B2 (en) 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030022910A1 (en) 2001-07-05 2003-01-30 R.T. Alamo Ventures I, Inc. Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine
US20030008005A1 (en) 2001-07-05 2003-01-09 R.T. Alamo Ventures, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
AU2002321885A1 (en) 2001-08-03 2003-02-24 Hill-Rom Services, Inc. Patient point-of-care computer system
US7144587B2 (en) * 2001-08-06 2006-12-05 Euro-Celtique S.A. Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
US7044302B2 (en) * 2001-09-19 2006-05-16 Avancen, Inc. Patient controlled timed oral medication dispenser
US7896192B2 (en) * 2001-09-19 2011-03-01 Avancen MOD Corp. Patient controlled timed medication dispenser
US7743923B2 (en) 2001-09-19 2010-06-29 Avanced MOD Corporation Patient controlled timed medication dispenser
OA12707A (en) * 2001-09-26 2006-06-26 Pharmacia Corp Intraorally disintegrating valdecoxib compositions.
EP1448456B1 (en) * 2001-10-22 2007-06-13 3M Innovative Properties Company Transdermal/transmucosal patch packaging
WO2003051363A1 (en) 2001-12-17 2003-06-26 Aryx Therapeutics Analgesic delivery systems and methods of use
CA2366887C (en) * 2001-12-31 2011-11-01 Michael Petersen Replicate incorporating an electronic content monitoring system for use in form-fill-seal applications
ATE442174T1 (de) 2002-02-22 2009-09-15 G W Pharma Ltd Spenderanordnung und vorrichtung
US7204425B2 (en) * 2002-03-18 2007-04-17 Precision Dynamics Corporation Enhanced identification appliance
US7074426B2 (en) * 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
GB0209783D0 (en) * 2002-04-29 2002-06-05 Glaxo Group Ltd Medicament dispenser
US6961541B2 (en) 2002-05-24 2005-11-01 Aeroscout, Inc. Method and apparatus for enhancing security in a wireless network using distance measurement techniques
US6793075B1 (en) * 2002-05-30 2004-09-21 Michael Jeter Container for dispensing a liquid and method of using the same
DE10226494A1 (de) 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
CN1662930B (zh) 2002-06-21 2010-10-27 葛兰素集团有限公司 用于分配装置的动作指示器
JP2004051502A (ja) * 2002-07-17 2004-02-19 Jcr Pharmaceuticals Co Ltd 成長ホルモン含有安定化粉末製剤
AU2003260367A1 (en) 2002-08-06 2004-02-25 Glaxo Group Limited A dispenser
US9486581B2 (en) 2002-09-11 2016-11-08 Becton, Dickinson And Company Injector device with force lock-out and injection rate limiting mechanisms
US7295890B2 (en) * 2002-09-26 2007-11-13 Stratamed Labs, Inc. Prescription drug compliance monitoring system
US6963289B2 (en) * 2002-10-18 2005-11-08 Aeroscout, Ltd. Wireless local area network (WLAN) channel radio-frequency identification (RFID) tag system and method therefor
US6999092B2 (en) 2002-10-25 2006-02-14 Fujitsu Limited Image display apparatus in which a specific area display attribute is modifiable
US6726053B1 (en) * 2002-10-29 2004-04-27 John E. Harrold Child resistant multiple dosage blister pack dispenser
GB0226022D0 (en) 2002-11-07 2002-12-18 Corporate Intellectual Propert Device
AU2003291037A1 (en) 2002-11-18 2004-06-15 Yaupon Therapeutics, Inc. Analgesic uses of norketamine and ketamine/norketamine prodrugs
ES2630222T3 (es) 2002-12-13 2017-08-18 Alphavax, Inc. Partículas alfavíricas y métodos de preparación
SI1587514T1 (sl) 2003-01-31 2006-10-31 Orexo Ab Hitro ucinkujoc farmacevtski sestavek
US20040253307A1 (en) 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
JP5475215B2 (ja) 2003-02-24 2014-04-16 ファーマシューティカル プロダクションズ， インコーポレイテッド 経粘膜薬物送達システム
GB0305581D0 (en) 2003-03-11 2003-04-16 Dallas Burston Ltd Dispensing devices
US20060062812A1 (en) 2003-03-11 2006-03-23 Calvin Ross Novel compositions
EP1613324A2 (en) 2003-04-14 2006-01-11 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7276246B2 (en) 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US6914668B2 (en) * 2003-05-14 2005-07-05 International Technologies (Laser) Ltd. Personal identification verification and controlled substance detection and identification system
BR0302017B1 (pt) 2003-06-02 2014-10-29 Ems Sigma Pharma Ltda Composição farmacêutica sublingual a base de um agonista do receptor central de benzodiazepínicos
US7819847B2 (en) * 2003-06-10 2010-10-26 Hewlett-Packard Development Company, L.P. System and methods for administering bioactive compositions
US20050049464A1 (en) 2003-08-29 2005-03-03 Lassers Harold Aaron Remote pharmaceutical administration device
US7248165B2 (en) 2003-09-09 2007-07-24 Motorola, Inc. Method and apparatus for multiple frequency RFID tag architecture
US20050065175A1 (en) 2003-09-24 2005-03-24 Xanodyne Pharmacal, Inc. Oral transmucosal methadone
WO2005032556A1 (en) 2003-10-02 2005-04-14 Elan Pharmaceuticals, Inc. Method for reducing pain
US8157788B2 (en) 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
US6999028B2 (en) * 2003-12-23 2006-02-14 3M Innovative Properties Company Ultra high frequency radio frequency identification tag
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
PL1708686T3 (pl) 2003-12-31 2011-08-31 Cima Labs Inc Doustna forma dawkowania fentanylu w postaci musującej o charakterze liniowym oraz sposoby jego podawania
US20070036853A1 (en) 2003-12-31 2007-02-15 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
DE602004031771D1 (de) 2003-12-31 2011-04-21 Cima Labs Inc Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
US20050150489A1 (en) * 2004-01-12 2005-07-14 Steve Dunfield Dispensing medicaments based on rates of medicament action
US20060026035A1 (en) 2004-07-28 2006-02-02 William Younkes Computer aided interactive medical management information and control system and method
US20060045865A1 (en) 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
US20060067978A1 (en) 2004-09-29 2006-03-30 Bausch & Lomb Incorporated Process for preparing poly(vinyl alcohol) drug delivery devices
US7119690B2 (en) 2004-10-08 2006-10-10 Proximities, Inc. Identification band using serpentine paths to detect tampering
US7388493B2 (en) 2004-10-08 2008-06-17 Bartronics America, Inc. Method and system for preventing unauthorized removal and use of an RFID apparatus
CN2776369Y (zh) 2004-10-22 2006-05-03 瓦索金爱尔兰有限公司 分配***
US20060089858A1 (en) 2004-10-25 2006-04-27 Tun Ling Means and method of applying RFID and PKI technologies for patient safety
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
JP2008534564A (ja) 2005-03-28 2008-08-28 オレクソ・アクチエボラゲット 痛みの治療に有用な新しい製薬組成物
US20070020186A1 (en) 2005-07-22 2007-01-25 Alpex Pharma S.A. Solid dosage formulations of narcotic drugs having improved buccal adsorption
US20070074722A1 (en) 2005-09-21 2007-04-05 Kurve Technology, Inc. Medicament delivery control, monitoring, and reporting system and method
US20070104763A1 (en) 2005-11-10 2007-05-10 Navinta Llc Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making
WO2007084247A2 (en) * 2005-12-28 2007-07-26 Alza Corporation Stable therapeutic formulations
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) * 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
WO2008085764A1 (en) 2007-01-05 2008-07-17 Acelrx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US9289583B2 (en) * 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9066847B2 (en) * 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8357114B2 (en) * 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8535714B2 (en) * 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
WO2007084290A2 (en) 2006-01-12 2007-07-26 Orexigen Therapeutics, Inc. Compositions of an anticonvulsant and psychotherapeutic and methods of using the same for reversing weight gain
US20070190130A1 (en) 2006-02-16 2007-08-16 Mark William A Protein hydrolysate excipients
US20070260491A1 (en) * 2006-05-08 2007-11-08 Pamela Palmer System for delivery and monitoring of administration of controlled substances
US20070286900A1 (en) 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
US20090010992A1 (en) * 2007-07-03 2009-01-08 Aceirx Pharmaceuticals, Inc. Drug formulations for oral transmucosal delivery to pediatric patients
ES2635137T3 (es) 2007-08-07 2017-10-02 Acelrx Pharmaceuticals, Inc. Formas de dosificación oral transmucosal que comprenden sufentanilo y triazolam
US8548623B2 (en) * 2009-03-18 2013-10-01 Acelrx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
US20110288128A1 (en) * 2010-05-21 2011-11-24 Acelrx Pharmaceuticals, Inc. Oral Transmucosal Administration of Sufentanil

Also Published As

Publication number Publication date
KR20110099017A (ko) 2011-09-05
NZ593512A (en) 2012-12-21
DK2367537T3 (da) 2013-01-07
AU2009316874B2 (en) 2016-06-16
BRPI0921519B1 (pt) 2021-10-13
SG171786A1 (en) 2011-07-28
CA2743261C (en) 2016-11-01
ES2396150T3 (es) 2013-02-19
CN102231980A (zh) 2011-11-02
AU2009316874A1 (en) 2011-07-07
US8945592B2 (en) 2015-02-03
PT2367537E (pt) 2013-01-22
BRPI0921519A8 (pt) 2021-09-28
US20100130551A1 (en) 2010-05-27
EP2367537A1 (en) 2011-09-28
JP2012509325A (ja) 2012-04-19
RU2011125316A (ru) 2012-12-27
RU2530579C2 (ru) 2014-10-10
CN102231980B (zh) 2014-07-16
CA2743261A1 (en) 2010-05-27
WO2010059504A1 (en) 2010-05-27
IL212880A (en) 2015-08-31
EP2367537B1 (en) 2012-10-17
BRPI0921519A2 (pt) 2017-05-30
IL212880A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
MX2011005370A (es) Formas de dosis orales de sufentanilo que comprenden agentes barredores de oxígeno y métodos de uso de los mismos.
IL229180A0 (en) Preparations and methods for the prevention of protein oxidation
SG178873A1 (en) Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
UA109123C2 (uk) Пробіотична композиція для застосування в лікуванні запалення кишечнику
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
MX2013003282A (es) Materiales y metodos para mejorar la funcion gastrointestinal.
EP2068798A4 (en) METHODS, COMPOSITIONS AND APPARATUSES FOR TREATING INJURIES USING ALTERED PRESSURES FROM ATMOSPHERIC PRESSURES
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
WO2009156484A3 (en) Organic compounds
IN2012DN01638A (es)
WO2009099719A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
MX2010003013A (es) Inhibicion de angiogenesis.
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
TN2011000482A1 (en) Organic compounds and their uses
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MY155299A (en) Oral dosage composition
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
MX2009012920A (es) Compuestos heptaciclicos y usos farmaceuticos de los mismos para la prevencion y tratamiento de diabetes y sindrome metabolico.
MX342947B (es) Tratamiento de diabetes tipo 2.
EP2381920A4 (en) METHOD AND COMPOSITIONS FOR TREATING P.ACNES
WO2012073047A3 (en) Compositions and methods
MX2013013649A (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
MX2009004142A (es) Metodo para prevenir o tratar sindrome metabolico.
WO2011130692A3 (en) Androgen induced oxidative stress inhibitors
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN

Legal Events

Date Code Title Description
FG Grant or registration